Hominax

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

pyridoxine hydrochloride, Quantity: 2.5 mg (Equivalent: pyridoxine, Qty 2.1 mg); zinc amino acid chelate, Quantity: 62.5 mg (Equivalent: zinc, Qty 12.5 mg); acetyl levocarnitine hydrochloride, Quantity: 125 mg; d-alpha-tocopheryl acid succinate, Quantity: 41.67 mg (Equivalent: d-alpha-tocopheryl acid succinate, Qty 50 IU); selenomethionine, Quantity: 87.4 microgram (Equivalent: selenium, Qty 35 microgram); ubidecarenone, Quantity: 25 mg; folic acid, Quantity: 200 microgram; Camellia sinensis, Quantity: 50 m

Available from:

Max Biocare Pty Ltd

INN (International Name):

Acetyl levocarnitine hydrochloride,Ascorbic acid,cysteine hydrochloride,Camellia sinensis,Cyanocobalamin,d-alpha-Tocopheryl acid

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; magnesium stearate; erythrosine; titanium dioxide; patent blue V; colloidal anhydrous silica; microcrystalline cellulose; starch sodium octenyl succinate; maize starch; sodium ascorbate; liquid glucose; dl-alpha-tocopherol; purified water; Gelatin; sodium lauryl sulfate

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Maintain/support general health and wellbeing ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Maintain/support reproductive system health ; Maintain/support healthy sexual function ; Maintain/support sperm health

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2015-11-16